{
    "clinical_study": {
        "@rank": "127624", 
        "acronym": "HOPE-Epilepsy", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }, 
            {
                "arm_group_label": "Omega 3 fatty acids supplementation", 
                "arm_group_type": "Experimental", 
                "description": "Omega 3 fatty acids capsules"
            }
        ], 
        "brief_summary": {
            "textblock": "This a multi-center study to examine whether supplementation with omega 3 fatty acids will\n      reduce seizure frequency in patients with epilepsy ."
        }, 
        "brief_title": "HOPE-Epilepsy Trial", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Epilepsy", 
        "condition_browse": {
            "mesh_term": "Epilepsy"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with active Epilepsy\n\n        Exclusion Criteria:\n\n          -  pregnant women or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "370", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744275", 
            "org_study_id": "HCor", 
            "secondary_id": "Research Institute - HCor"
        }, 
        "intervention": [
            {
                "arm_group_label": "Omega 3 fatty acids supplementation", 
                "intervention_name": "Omega 3 fatty acids", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "corn oil", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Epilepsy", 
            "Omega 3 fatty acids"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "04005-909"
                }, 
                "name": "Research Institute, Hospital do Cora\u00e7\u00e3o"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "High Dose Omega 3 Fatty Acids Supplementation in Patients With Epilepsy : The HOPE-Epilepsy Trial", 
        "overall_official": [
            {
                "affiliation": "Hospital do Coracao", 
                "last_name": "M J Carrion, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital do Coracao", 
                "last_name": "O Berwanger, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "BCRI", 
                "last_name": "R D Lopes, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Federal University of S\u00e3o Paulo", 
                "last_name": "F A Scorza, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "Brazil: Ethics Comittee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "number of seizures during the treatment period", 
            "measure": "Seizure Frequency", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744275"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "number of crises categorized as: generalized, focal with disconnection and focal without disconnection", 
                "measure": "categorized seizure frequency", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "description": "percentage of reduction or increase in seizure frequency  from baseline til the end of treatment period", 
                "measure": "Percentage of overall seizure frequency modification", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "Time Free of seizures during treatment", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Reduction in seizure frequency", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Hospital do Coracao", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital do Coracao", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014", 
        "why_stopped": "Lack of funding"
    }
}